Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Cognipharma's HCP Engagement Platform represents a Software as a Service (SaaS) offering tailored for pharmaceutical companies that seek to refine their omnichannel approaches and cultivate valuable relationships with healthcare professionals. This platform provides effortless integration with various Customer Relationship Management (CRM) systems like Veeva, IQVIA OCE, Salesforce, as well as custom-built solutions, thereby facilitating a unified management of customer information. Among its standout features are instantaneous HCP registration and validation processes, which grant quick access to content via single sign-on while ensuring verification against public databases or existing CRM data. Additionally, the platform prioritizes the management of consent and preferences, allowing for the gradual collection of channel and content preferences that help tailor communications to meet the expectations of healthcare professionals. By offering a high level of content personalization and optimizing channel interactions, Cognipharma's solution is designed to enhance marketing and sales performance metrics, providing valuable insights into customer journeys across various channels and pinpointing the most effective strategies for re-engagement. Ultimately, this comprehensive approach not only supports better decision-making but also fosters stronger connections between pharmaceutical companies and healthcare providers.
Description
Sorcero is an innovative platform powered by artificial intelligence that aims to convert intricate medical data into practical insights for the life sciences sector. It offers a range of products such as Medical Insights Management, Intelligent Publication Monitoring, Plain Language Summaries, and Intelligent Systematic Literature Review, all of which work together to unify and interpret both structured and unstructured data from diverse sources. By leveraging AI to dissect medical themes, notes, and research findings, Sorcero provides clear and high-quality responses to challenging medical inquiries, thereby assisting teams in Medical Affairs, Pharmacovigilance, and Regulatory Affairs in making better-informed choices. The platform enhances rapid literature monitoring, facilitates content creation, and supports evidence-based decision-making, significantly improving patient outcomes while also streamlining operational processes. Additionally, Sorcero's capabilities can lead to a more effective collaboration among various stakeholders within the healthcare ecosystem.
API Access
Has API
No
API Access
Has API
No
Integrations
IQVIA
Yes
Microsoft Excel
No
Microsoft Word
No
Reddit
No
Salesforce
Yes
Veeva CRM
Yes
Integrations
IQVIA
No
Microsoft Excel
Yes
Microsoft Word
Yes
Reddit
Yes
Salesforce
No
Veeva CRM
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Cognipharma
Founded
2016
Country
Portugal
Website
www.cognipharma.com/hcp-engagement-platform/
Vendor Details
Company Name
Sorcero
Founded
2017
Country
United States
Website
www.sorcero.com
Product Features
Product Features
Qualitative Data Analysis
Annotations
No
Collaboration
No
Data Visualization
No
Media Analytics
No
Mixed Methods Research
No
Multi-Language
No
Qualitative Comparative Analysis
No
Quantitative Content Analysis
No
Sentiment Analysis
No
Statistical Analysis
No
Text Analytics
No
User Research Analysis
No